Maxcyte

MXCTNasdaq United States Health Care Biotechnology: Commercial Physical & Biological Resarch

Market cap

$127.976 M

$1.24 +1.64%

Close of 22 Sept 2026

Revenue

$33.0M

#2855 by revenue

Earnings

-$44.6M

Loss-making

Shares outstanding

103,206,206

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Commercial Physical & Biological Resarch, ranked by market cap

All 12 →

#7OmniAbOABI$715.3M
#8Nrc HealthNRC$483.5M
#9MaxcyteMXCT$128.0M
#10OneMedNetONMD$38.5M
#11bioAffinity TechnologiesBIAF$9.98M

What if Maxcyte were worth as much as…

Open the what-if tool →

Gold $30.2T

$292,947.21

Per share 236,248× higher

Bitcoin $1.74T

$16,875.49

Per share 13,609× higher

Nvidia $5.52T

$53,444.14

Per share 43,100× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Maxcyte are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.